Pricing Log in Create free account

Eupraxia Pharmaceuticals Inc. (EPRX) vs Prothena Corporation plc (PRTA)

Eupraxia Pharmaceuticals Inc. and Prothena Corporation plc are both Biotechnology companies. Eupraxia Pharmaceuticals Inc. and Prothena Corporation plc are of similar size ($446.2M and $436.4M). Eupraxia Pharmaceuticals Inc. has the higher net margin (0.00% vs −80.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Prothena Corporation plc leads on 7 and Eupraxia Pharmaceuticals Inc. on 5.

Valuation

Metric EPRX PRTA Biotechnology median
P/E n/m n/m 8.50
P/S n/m 7.98 9.71
P/B 4.38 1.52 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 2.70 9.21
Earnings yield (15.41%) (9.94%) (33.15%)
Free cash flow yield (8.72%) (13.96%) (25.50%)

Profitability

Metric EPRX PRTA Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (101.80%) 0.00%
Net margin 0.00% (80.67%) 0.00%
Free cash flow margin 0.00% (111.49%) 0.00%
Return on equity (117.82%) (14.39%) (56.36%)
Return on assets (64.44%) (12.54%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EPRX PRTA Biotechnology median
Revenue growth (TTM) — 427.32% 6.02%
EPS growth (last fiscal year) (35.53%) (99.56%) 30.26%
Revenue growth, 5-year CAGR — 62.56% 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric EPRX PRTA Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 16.00 25.05 4.72
Net debt to EBITDA 2.11 1.46 0.96

Dividend

Metric EPRX PRTA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric EPRX PRTA Biotechnology median
Market cap 446.21m 436.36m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack